Myprotein’s Post

🌟 It's time we (re)introduce ourselves: Hi, we’re Thaena®, the proud makers of ThaenaBiotic®. Thaena®, pronounced | thay-nah |, is a female-founded, Pacific Northwest-based company. Our mission is simple: To use science, radical innovation, and the microbiome to help people feel better. We believe in using the innate wisdom of the human body to shift the paradigms of medicine by expanding access to microbiome supports and putting postbiotics on the map. 🎯 Our flagship product, ThaenaBiotic®, is a testament to this. The world’s first stool-derived, complex postbiotic supplement, ThaenaBiotic® contains an ecosystem of postbiotic signaling molecules prebiotic fiber, heat-killed probiotics, and cell fragments harmoniously working together—making it not just a supplement, but an embodiment of our holistic approach. 🌿 Have questions or want to get in touch? We love talking sh!t. Send us a DM, email us at [email protected], or call us at 503.506.8732 🤸♀️

📢 𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀! ProDigest is attending this year’s Future Food-Tech summit in San Francisco! 🔍 𝗪𝗵𝗼 𝗮𝗿𝗲 𝘄𝗲? We are a #preclinical CRO providing the 𝗯𝗲𝘀𝘁-𝗶𝗻-𝗰𝗹𝗮𝘀𝘀 in vitro and ex vivo gastrointestinal simulations 🌱 We aid the food, feed, and drug industry in understanding how digestion and the gut microbiome impact their products✨ 🔬 𝗪𝗵𝗮𝘁 𝘁𝗼 𝗲𝘅𝗽𝗲𝗰𝘁 𝗳𝗿𝗼𝗺 ProDigest? •𝗔 𝗿𝗮𝗻𝗴𝗲 𝗼𝗳 𝗴𝗮𝘀𝘁𝗿𝗼𝗶𝗻𝘁𝗲𝘀𝘁𝗶𝗻𝗮𝗹 𝗺𝗼𝗱𝗲𝗹𝘀 that mimic human digestion for game-changing insights that serve as a #derisking strategy for #clinicaltrials. •𝗧𝗮𝗶𝗹𝗼𝗿-𝗺𝗮𝗱𝗲 solutions for diverse products & conditions. •𝗣𝗿𝗼𝘃𝗲𝗻 𝗲𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲 from early phases to product development. ✅ 𝗢𝘂𝗿 𝗺𝗼𝘁𝗼: 𝘌𝘷𝘦𝘳𝘺𝘵𝘩𝘪𝘯𝘨 𝘵𝘩𝘢𝘵 𝘪𝘴 𝘪𝘯𝘨𝘦𝘴𝘵𝘦𝘥 𝘤𝘢𝘯 𝘣𝘦 𝘵𝘦𝘴𝘵𝘦𝘥 🔬 📈 𝗖𝗼𝗻𝗻𝗲𝗰𝘁 𝘄𝗶𝘁𝗵 𝗨𝘀: Meet Bart Roucourt and Peter B. Azmi to explore success stories and join the movement towards ethical, impactful research. #microbiome #guthealth #innovation #foodtechnology #alternativeproteins #novelfoods

Postbiotics and Exometabolome 🎙️ We will be speaking at the 12th Probiotics Prebiotics & NewFood!"🌿 What are postbiotics and why is it important to know their exometabolome for their industrial exploitation? From the collaboration between BiCT Fonterra and the University of Bari, we will present this study that lays solid scientific foundations for product efficacy, the identification of bioactive compounds, for increasingly standardised, innovative and safe ingredients for the consumer. Furthermore, the understanding of the exometabolome may allow the customisation of postbiotics to individual needs, adapting the composition of products to address specific health problems or microbiome conditions. Postbiotics, together with an understanding of the exometabolome, represent a promising area of research and development, offering potential human health benefits and opportunities for the food, cosmetics and pharmaceutical industries. Dr Marianna Ciaccia, our biotechnology expert, will be a speaker at the 12th Probiotics, Prebiotics & New Food Congress. Join us to discover the latest innovations in the field of nutraceutics. Don't miss this opportunity! 📅 Save the date: 17 September 2023 📍 Venue: Rome, Auditorium della Tecnica Contact us! [email protected] Marianna Ciaccia Maurizio Bettiga Isabella Pisano Gennaro Agrimi Università degli Studi di Bari Matthew O'Connor Rolando Saltini #Bict #fonterra #12thProbioticsPrebioticsNewFood #foodsupplements #cosmetics #researchdevelopment https://lnkd.in/gYHDUVCZ

✨ 𝗗𝗼 𝘆𝗼𝘂 𝘄𝗮𝗻𝘁 𝘁𝗼 𝗯𝗼𝗼𝘀𝘁 𝘆𝗼𝘂𝗿 #𝗺𝗶𝗰𝗿𝗼𝗯𝗶𝗼𝗺𝗲 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁? 🚀 𝗖𝗼𝗻𝗻𝗲𝗰𝘁 𝘄𝗶𝘁𝗵 𝗣𝗿𝗼𝗗𝗶𝗴𝗲𝘀𝘁 𝗮𝘁 #𝗽𝗿𝗼𝗯𝗶𝗼𝘁𝗮𝗴𝗹𝗼𝗯𝗮𝗹 💡𝗦𝘁𝗮𝘆 𝗮𝗵𝗲𝗮𝗱: Benefit from the best-in-class 𝘪𝘯 𝘷𝘪𝘵𝘳𝘰 and 𝘦𝘹 𝘷𝘪𝘷𝘰 gastrointestinal simulations and uncover innovative, tailor-made solutions designed to meet your unique needs. The power of ProDigest's models will help you: 📈 𝗢𝗽𝘁𝗶𝗺𝗶𝘇𝗲 𝘆𝗼𝘂𝗿 𝗳𝗼𝗿𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀: Get detailed insights into your product’s stability and targeted release during gastrointestinal transit. 🔬 𝗨𝗻𝗹𝗼𝗰𝗸 𝗺𝗶𝗰𝗿𝗼𝗯𝗶𝗼𝗺𝗲 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀:  Evaluate the impact of the gut microbiome on your product and vice versa. 🔍𝗨𝗻𝗰𝗼𝘃𝗲𝗿 𝘁𝗵𝗲 𝗶𝗻𝘁𝗲𝗿𝗮𝗰𝘁𝗶𝗼𝗻𝘀 between the microbiome, host, and your product. 🔗 𝗖𝗼𝗻𝗻𝗲𝗰𝘁 𝘄𝗶𝘁𝗵 𝘂𝘀: Meet Bart Roucourt and Dora Akritidou to discover possibilities for strategic partnerships that will elevate your R&D pipeline and drive innovation! 📍 𝗙𝗶𝗻𝗱 𝘂𝘀 at our booth! #microbiome #guthealth #probiotics #postbiotics #prebiotics #synbiotics #Probiota ProDigest

CSL USA can't wait to meet you at SupplySide West. Our second pillar that we are unveiling today, is one of the fastest growing areas in the microbiome space today, Postbiotics. With a recently published study for immunity on our CRL 1505 HI strain, we offer the latest innovation which can be used in many applications beyond capsules. Want to know more? Come chat with us at booth 5676. We are curious what objectives you have for postbiotics. #CSLUSA #SupplySideWest #Probiotics #DietarySupplements #Microbiome #Postbiotics

Postbiotics and Exometabolome 🎙️ We will be speaking at the 12th Probiotics Prebiotics & NewFood!"🌿 What are postbiotics and why is it important to know their exometabolome for their industrial exploitation? From the collaboration between BiCT Fonterra and the University of Bari, we will present this study that lays solid scientific foundations for product efficacy, the identification of bioactive compounds, for increasingly standardised, innovative and safe ingredients for the consumer. Furthermore, the understanding of the exometabolome may allow the customisation of postbiotics to individual needs, adapting the composition of products to address specific health problems or microbiome conditions. Postbiotics, together with an understanding of the exometabolome, represent a promising area of research and development, offering potential human health benefits and opportunities for the food, cosmetics and pharmaceutical industries. Dr Marianna Ciaccia, our biotechnology expert, will be a speaker at the 12th Probiotics, Prebiotics & New Food Congress. Join us to discover the latest innovations in the field of nutraceutics. Don't miss this opportunity! 📅 Save the date: 17 September 2023 📍 Venue: Rome, Auditorium della Tecnica Contact us! [email protected] Marianna Ciaccia Maurizio Bettiga Isabella Pisano Gennaro Agrimi  Università degli Studi di Bari Matthew O'Connor Rolando Saltini #Bict #Fonterra #12thProbioticsPrebioticsNewFood #foodsupplements #cosmetics #researchdevelopment

Only four weeks until Probiota 2024! I'm excited to gain insights into the latest developments in the microbiome industry and connect with numerous forward-thinking leaders in this dynamic field. Will I see you there? If so, let's connect! #probiota #gutmicrobiome #microbiome #probiotics #postbiotics

An engaging conversation with OptiBiotix Health CEO Stephen O'Hara! With partnerships lined up with global giants like DSM/Firminech, OptiBiotix is set to make remarkable advancements. Investors eagerly anticipate a critical event that could illuminate the company and draw new investors. Exciting times ahead! Introduction: In a candid conversation with the editor-in-chief and my father, Elric Langton, Stephen O'Hara, CEO of OptiBiotix Health, delves deep into the company's performance, strategies, and future prospects. As the microbiome industry evolves, OptiBiotix stands at the forefront, navigating challenges and capitalising on opportunities. During the conversation, we look at the company's difficult and turbulent journey and what lies ahead for potential investors. Summary: Stephen O'Hara paints a picture of a company that has faced its fair share of challenges but remains resilient and forward-looking. The past few years have seen OptiBiotix navigating the complexities of the microbiome industry with a focus on probiotics, prebiotics, and skincare. This is an evolving area of healthcare with new science and opportunities in which not all companies in this space, for example, 4D pharma and UBiome, have survived. The company's strategy of diversifying its portfolio and expanding into different areas of the microbiome has been met with both successes and setbacks. A significant point of discussion was the company's venture into SweetBiotix, a novel sweet fibre. While the product holds promise, its uniqueness has meant the journey to market has been marked by significant technical, scientific, and manufacturing challenges, of which the majority have now been overcome. Partnering with global giants like DSM/Firminech, OptiBiotix is poised to make significant strides in this space; a critical event eagerly awaited by investors could shine a bright light on the company and, by doing so, attract new investors. DSM, a Dutch health and nutrition powerhouse, has joined forces with the Swiss flavour and fragrance giant Firmenich International. Together, they boast a formidable presence with 30,000 employees across 340 locations in 60 countries. Their combined valuation is a staggering $131 billion, with an annual turnover surpassing $16 billion. This merger significantly amplifies their potential in the probiotics market, which was valued at approximately $58 billion in 2022 and is projected to soar to over $85 billion by 2027. is.gd/Whu4LF #OPTI #microbiome #probiotics #probiotics #Investing

Postbiotics and Exometabolome 🎙️ We will be speaking at the 12th Probiotics Prebiotics & NewFood!"🌿 What are postbiotics and why is it important to know their exometabolome for their industrial exploitation? From the collaboration between BiCT Fonterra and the University of Bari, we will present this study that lays solid scientific foundations for product efficacy, the identification of bioactive compounds, for increasingly standardised, innovative and safe ingredients for the consumer. Furthermore, the understanding of the exometabolome may allow the customisation of postbiotics to individual needs, adapting the composition of products to address specific health problems or microbiome conditions. Postbiotics, together with an understanding of the exometabolome, represent a promising area of research and development, offering potential human health benefits and opportunities for the food, cosmetics and pharmaceutical industries. Dr Marianna Ciaccia, our biotechnology expert, will be a speaker at the 12th Probiotics, Prebiotics & New Food Congress. Join us to discover the latest innovations in the field of nutraceutics. Don't miss this opportunity! 📅 Save the date: 17 September 2023 📍 Venue: Rome, Auditorium della Tecnica Contact us! [email protected] Marianna Ciaccia Maurizio Bettiga Isabella Pisano Gennaro Agrimi Università degli Studi di Bari Matthew O'Connor Rolando Saltini #Bict #fonterra #12thProbioticsPrebioticsNewFood #foodsupplements #cosmetics #researchdevelopment https://lnkd.in/gthx2uKf